Mutual exclusivity analysis identifies oncogenic network modules.
about
Cancer genome landscapesComprehensive molecular characterization of human colon and rectal cancerComprehensive molecular portraits of human breast tumoursStrategies for Integrated Analysis of Genetic, Epigenetic, and Gene Expression Variation in Cancer: Addressing the ChallengesUnderstanding Genotype-Phenotype Effects in Cancer via Network ApproachesIntegrative approaches for finding modular structure in biological networksVisualizing multidimensional cancer genomics dataBioinformatics for cancer immunology and immunotherapyStructure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewEmerging patterns of somatic mutations in cancerInferring Aberrant Signal Transduction Pathways in Ovarian Cancer from TCGA DataCancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.Comprehensive molecular characterization of clear cell renal cell carcinoma.Computational characterisation of cancer molecular profiles derived using next generation sequencingIntegrated genomic characterization of papillary thyroid carcinomaComprehensive Molecular Portraits of Invasive Lobular Breast CancerComprehensive genomic characterization of squamous cell lung cancers.Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortalIntegrated genomic characterization of endometrial carcinomaThe somatic genomic landscape of glioblastomaStatistical Methods in Integrative GenomicsSystematic identification of combinatorial drivers and targets in cancer cell linesAn Evolutionary Approach for Identifying Driver Mutations in Colorectal CancerComputational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer ProgressionGain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug SensitivityIdentifying Driver Genomic Alterations in Cancers by Searching Minimum-Weight, Mutually Exclusive SetsNecrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptionsBreakthroughs in genomics data integration for predicting clinical outcomePathway and network analysis of cancer genomesUsing biological pathway data with paxtools.Identification of ovarian cancer driver genes by using module network integration of multi-omics data.Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.Collection, integration and analysis of cancer genomic profiles: from data to insight.Integrated analysis of mutation data from various sources identifies key genes and signaling pathways in hepatocellular carcinoma.Mining TCGA data using Boolean implicationsIdentifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data.Simultaneous inference of cancer pathways and tumor progression from cross-sectional mutation data.Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.Pan-cancer analysis of TCGA data reveals notable signaling pathways.Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
P2860
Q22242276-181EC982-6A33-4163-AABB-F910CED18DFBQ24630415-4642C753-FD2E-45E6-A151-380B9E73181AQ24630844-4CC56428-415D-40E7-A845-6BDE65ACCC16Q26766390-6AE61FB7-82C7-4AF0-B6E4-74922C79B1D4Q26766543-D4F7F7C5-9F69-45B8-AAB3-C454A32BFAB7Q26824897-A36D2F01-FF08-4360-B56F-EE4DB3653D4FQ26860645-4275CF85-A49E-4110-A1E6-7121DB8AA886Q26864876-587E1ABB-50BD-4DD6-A6ED-6A0F76BA0411Q27008867-593AD698-C6B3-40AD-BC24-E84217A4582EQ27014126-E607F569-AA37-439B-9B20-0EFF4FF82A91Q27021747-EFCA128D-3AC3-4D3A-A3F9-EAC39619F785Q27690285-5C720EB9-557D-41A5-8712-A288496ABF08Q27852374-BE373DA8-3CF3-41E3-9E13-A9594F6F8D6FQ28080523-A67C7127-79E7-4823-9C6E-E2CC0C278A1EQ28251986-D8DC51BA-8AF1-49A8-A0DD-F01E73C75E53Q28268284-94284E44-A124-4EA1-9FD4-AF26D3E69DE4Q28274701-4E23279B-6101-49FF-A0AD-A7DB55D1D0B6Q28288215-DF6F9BEE-8F2A-4F1C-9134-675098C1713EQ28289962-CC3B80C4-F50A-4071-8965-BB2A06B6AC8EQ28300185-51C200DC-EE4B-489E-ABA8-7AF4E11E03BAQ28385219-1466579A-158B-4F5B-9618-9AAB31509031Q28486051-32451A21-C29A-41D3-8D91-1A03625E3151Q28548216-1F4D3526-434F-4067-A7EE-862EABD0BF8FQ28552533-FD9C8280-EE94-45C6-BE54-A7A119E4DB9CQ28553888-BEF5B81A-8EE7-41A3-92DE-27D1062C73CFQ28608346-2D6DE905-5E28-43B9-B81E-1D263ED300B8Q28652643-FF99A37A-8D4F-4B43-841D-CF4F1C477CE6Q28708853-B0F12C41-6050-43F9-BF69-12F13F1EAA8FQ28914768-DA2DF46B-928C-4142-9453-F9E74885EE00Q30670257-EAD3E476-EC65-4BF6-9EBF-A29000D7B3F1Q30753342-A642011E-9A05-4C01-82CA-2B1BB1FC1664Q30763468-6D2A7647-5239-4D4A-92CB-E30FDC2DA576Q30768176-6759463D-AFD5-4C52-9445-97E22FC372BDQ30834745-90EE5888-66EE-474D-946E-91E0010BEFDDQ30838107-C6FF629E-6FD8-405E-804D-20E6F3816635Q30887798-34A0EAEC-B692-4482-A343-9AC86B6C698DQ30912170-C0717EC7-A2F3-453C-8AC1-3B9B62209591Q30916859-1C309511-7FAA-418D-AACC-7B32CA0FBC55Q30980050-B1AD84D4-51C3-4891-AFD9-BE3D59D352B7Q30983525-123CB980-70C1-4498-AFB7-955404899286
P2860
Mutual exclusivity analysis identifies oncogenic network modules.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mutual exclusivity analysis identifies oncogenic network modules.
@ast
Mutual exclusivity analysis identifies oncogenic network modules.
@en
type
label
Mutual exclusivity analysis identifies oncogenic network modules.
@ast
Mutual exclusivity analysis identifies oncogenic network modules.
@en
prefLabel
Mutual exclusivity analysis identifies oncogenic network modules.
@ast
Mutual exclusivity analysis identifies oncogenic network modules.
@en
P2860
P50
P356
P1433
P1476
Mutual exclusivity analysis identifies oncogenic network modules.
@en
P2093
Chris Sander
Ethan Cerami
P2860
P304
P356
10.1101/GR.125567.111
P577
2011-09-09T00:00:00Z